Figure 6From: Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatinToxicity observation I. H & E staining of heart(a), liver(b), lung (c), spleen(d) and kidney(e) in recipient mice. No hemorrhage in organs appeared in the combination group and no differences were seen among groups. A: Ad-hEndo+ cisplatin; B: Ad-hEndo; C: cisplatin; D: Ad-null; E: NS.Back to article page